Variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases
- 1 January 2015
- journal article
- clinical trial
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 399, 244-249
- https://doi.org/10.1016/j.mce.2014.10.013
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81270871)
- Key Disciplines Development of Shanghai Jinshan District (2012-23)
This publication has 24 references indexed in Scilit:
- MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new playersActa Endocrinologica, 2014
- Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cellsAutoimmunity, 2014
- Genome‐Wide DNA Methylation Patterns in Naive CD4+ T Cells From Patients With Primary Sjögren's SyndromeArthritis & Rheumatology, 2013
- Power and sample size calculations for Mendelian randomization studies using one genetic instrumentInternational Journal of Epidemiology, 2013
- New insight on the Xq28 association with systemic sclerosisAnnals Of The Rheumatic Diseases, 2013
- Association of an activity‐enhancing variant of IRAK1 and an MECP2–IRAK1 haplotype with increased susceptibility to rheumatoid arthritisArthritis & Rheumatism, 2012
- Power Calculations in Genetic StudiesCold Spring Harbor Protocols, 2012
- Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: Association with the functional IRAK1 196Phe/532Ser haplotypeArthritis & Rheumatism, 2011
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Methylated DNA and MeCP2 recruit histone deacetylase to repress transcriptionNature Genetics, 1998